Neil Riordan

Neil Riordan, PA, PhD, is a businessman and research scientist who has made significant contributions to integrative medicine, particularly in the area of cancer therapies. He acts as the founder and Chief Executive Officer of Aidan Incorporated, an organization that includes Aidan Clinic, which provided care for patients with cancer, and Aidan Products, which offers an array of supplements designed to optimize health. Neil Riordan additionally serves as the President of Medistem Panama, Inc., which is involved in stem cell research.

Neil Riordan holds a Bachelor of Science in Physician Assistant Studies, magna cum laude, from Wichita State University. He graduated from the College of Medicine at University of Nebraska Medical Center with a Master of Science in Physician Assistant Studies and obtained his Doctor of Philosophy in Health Sciences from Medical University of the Americas. Dr. Riordan has since held numerous research and executive positions with such organizations and initiatives as the Center for the Improvement of Human Functioning, the RECNAC project, ITL Cancer Clinic, and the Bio-Communications Research Institute.

In his capacity as a researcher, Neil Riordan has made several significant discoveries, including a molecule in bindweed that prevents new blood vessels from growing, thus preventing the spread of abnormal tissue. He also discovered another blood vessel growth-inhibiting molecule in the cell wall of a bacterium. In 2010 he was issued a patent for a novel cellular vaccine for cancer patients. In 2005, Dr. Riordan and his father, Hugh Riordan, M.D. wrote what has become a seminal scientific paper on the preferential toxicity of vitamin C to cancer cells. That discovery led to a patent on the treatment of cancer with vitamin C which issued in 1997. Dr. Riordan holds several other patents for his discoveries, and his research has appeared in numerous medical journals, including the British Journal of Cancer, Journal of Translational Medicine, and Anticancer Research. He has also served as an invited reviewer for Cell Transplantation, the Journal of Translation Medicine, and Archives of Medical Research, among many others.